Morin Disrupts Cytoskeleton Reorganization in Osteoclasts through an ROS/SHP1/c-Src Axis and Grants Protection from...

Area of Science:

• Biochemistry
• Pharmacology
• Immunology

Background:

• Morin is a flavonoid with known anti-inflammatory and antioxidative properties.
• Inflammatory bone loss is a significant clinical concern, often linked to oxidative stress.

Purpose of the Study:

• To investigate the potential of morin in preventing inflammatory bone loss.
• To elucidate the molecular mechanisms underlying morin's effects on osteoclasts.

Main Methods:

• Lipopolysaccharide (LPS)-induced bone loss model in mice.
• Analysis of osteoclast differentiation and activity using TRAP staining and actin ring formation assays.
• Assessment of intracellular signaling pathways, including reactive oxygen species (ROS) and c-Src activation.

Main Results:

• Morin administration prevented LPS-induced bone loss in mice.
• Morin significantly reduced osteoclast number and activity in vitro and in vivo.
• Morin inhibited the ROS/SHP1/c-Src signaling axis, crucial for osteoclast cytoskeletal organization.

Conclusions:

• Morin effectively protects against inflammatory bone loss by modulating osteoclast function.
• The protective effect is mediated through the disruption of the ROS/SHP1/c-Src pathway.
• Morin demonstrates significant therapeutic potential for treating inflammatory bone loss conditions.